EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases

Phase 3

Active, not recruiting

Conditions: Zika
Chikungunya
Aedes-borne Diseases
Dengue

Interventions: Biological: Targeted Indoor Residual Spraying (TIRS)

First Posted Date: 2020-04-13

Last Posted Date: 2024-05-14

Lead Sponsor: Emory University

Target Recruit Count: 4702

Registration Number: NCT04343521

Locations: 🇲🇽
Universidad Autonoma de Yucatan, Merida, Yucatan, Mexico

Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade

Phase 2

Recruiting

Conditions: Metastatic Non-Small Lung Cell Cancer
Stage IV Lung Cancer AJCC v8
Stage IVA Lung Cancer AJCC v8
Stage IVB Lung Cancer AJCC v8
Recurrent Non-Small Lung Cell Cancer

Interventions: Drug: Docetaxel
Biological: Pembrolizumab
Biological: Ramucirumab

First Posted Date: 2020-04-10

Last Posted Date: 2024-02-13

Lead Sponsor: Emory University

Target Recruit Count: 41

Registration Number: NCT04340882

Locations: 🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸
Grady Health System, Atlanta, Georgia, United States

WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors

Phase 1

Completed

Conditions: Brain Tumor
Medulloblastoma
Brain Metastases

Interventions: Drug: WP1066

First Posted Date: 2020-04-06

Last Posted Date: 2023-02-21

Lead Sponsor: Emory University

Target Recruit Count: 10

Registration Number: NCT04334863

Locations: 🇺🇸
Children's Healthcare of Atlanta (CHOA), Atlanta, Georgia, United States

Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19

Not Applicable

Completed

Conditions: COVID-19

Interventions: Device: GO2 PEEP MOUTHPIECE

First Posted Date: 2020-04-02

Last Posted Date: 2021-02-18

Lead Sponsor: Emory University

Target Recruit Count: 2

Registration Number: NCT04331366

Locations: 🇺🇸
Emory St. Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

AflacLL1901 (CHOA-AML)

Phase 2

Terminated

Conditions: Acute Myeloid Leukemia
AML, Childhood

Interventions: Drug: Cytarabine
Drug: Daunorubicin
Drug: Erwinase
Drug: Etoposide
Drug: Gemtuzumab ozogamicin
Procedure: Stem cell transplantation (SCT)
Drug: Sorafenib

First Posted Date: 2020-03-30

Last Posted Date: 2022-06-15

Lead Sponsor: Emory University

Target Recruit Count: 8

Registration Number: NCT04326439

Locations: 🇺🇸
Egleston Hospital, Atlanta, Georgia, United States

Faith-Based Toolbox for African Americans With Dementia

Not Applicable

Completed

Conditions: Dementia
Alzheimer Disease

Interventions: Behavioral: Faith-based Home Activity Toolbox (Faith-HAT)

First Posted Date: 2020-03-27

Last Posted Date: 2024-10-08

Lead Sponsor: Emory University

Target Recruit Count: 54

Registration Number: NCT04325204

Locations: 🇺🇸
Emory University, Nell Hodgson Woodruff School of Nursing, Fairburn, Georgia, United States

The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI

Not Applicable

Recruiting

Conditions: Coronary Artery Disease

Interventions: Diagnostic Test: PET-MPI Protocol
Diagnostic Test: CT-MPI
Diagnostic Test: CT-FFR
Drug: Regadenoson

First Posted Date: 2020-03-20

Last Posted Date: 2024-04-15

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT04316676

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Dry Needling for Cervicogenic Headache

Not Applicable

Completed

Conditions: Cervicogenic Headache
Headache

Interventions: Procedure: Dry Needling
Other: Upper extremity stretching program

First Posted Date: 2020-03-12

Last Posted Date: 2020-05-19

Lead Sponsor: Emory University

Target Recruit Count: 7

Registration Number: NCT04305223

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Biomarkers for Event-driven PrEP Adherence

Phase 4

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Drug: Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC)

First Posted Date: 2020-03-06

Last Posted Date: 2024-04-15

Lead Sponsor: Emory University

Target Recruit Count: 48

Registration Number: NCT04298697

Locations: 🇺🇸
Hope Clinic, Atlanta, Georgia, United States

Are Opioids Needed After ACL Reconstruction

Phase 4

Completed

Conditions: Anterior Cruciate Ligament Rupture

Interventions: Drug: Placebo oral tablet
Drug: Oxycodone

First Posted Date: 2020-02-26

Last Posted Date: 2023-10-11

Lead Sponsor: Emory University

Target Recruit Count: 98

Registration Number: NCT04285853

Locations: 🇺🇸
Emory clinic at Executive Park, Atlanta, Georgia, United States
🇺🇸
The Emory Clinic, Atlanta, Georgia, United States
🇺🇸
Emory Orthopedic and spine Hospital, Tucker, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy